DaVita Inc. 3rd Quarter 2019 Results
DaVita Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2019. Third quarter 2019 financial and operational highlights: Consolidated revenues of $2.904 billion....
DaVita Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2019. Third quarter 2019 financial and operational highlights: Consolidated revenues of $2.904 billion....
DaVita Clinical Research (DCR) is set to present 10 research abstracts from company representatives and medical professionals at the American Society of Nephrology (ASN) annual Kidney Week in...
The recently announced Nephrology Care Alliance (NCA), a platform seeking to empower more physicians to succeed in integrated kidney care, is excited to be joined by Dr. Leslie Wong as its first...
Nephrology Care Alliance (NCA), a new entity seeking to empower physicians to succeed in a changing health care environment, announced that it has confirmed interest from over 500 nephrologists to...
Vively Health, a risk-based provider delivering home-based primary care to the nation's Most Vulnerable Patients (MVPs), today announced a five-year collaboration with Cerner Corporation (Nasdaq:...